218 related articles for article (PubMed ID: 29089059)
1. Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
Binns EL; Moraitis E; Maillard S; Tansley S; McHugh N; Jacques TS; Wedderburn LR; Pilkington C; Yasin SA; Nistala K;
Pediatr Rheumatol Online J; 2017 Oct; 15(1):77. PubMed ID: 29089059
[TBL] [Abstract][Full Text] [Related]
2. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
Dandasena T; Ingle V; Singhai A; Saigal S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
[TBL] [Abstract][Full Text] [Related]
3. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
[TBL] [Abstract][Full Text] [Related]
4. [Immune-Mediated Necrotizing Myopathy].
Uruha A
Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
[TBL] [Abstract][Full Text] [Related]
5. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
7. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.
Melki I; Devilliers H; Gitiaux C; Bondet V; Duffy D; Charuel JL; Miyara M; Bokov P; Kheniche A; Kwon T; Authier FJ; Allenbach Y; Belot A; Bodemer C; Bourrat E; Dumaine C; Fabien N; Faye A; Frémond ML; Hadchouel A; Kitabayashi N; Lepelley A; Martin-Niclos MJ; Mudumba S; Musset L; Quartier P; Rice GI; Seabra L; Uettwiller F; Uggenti C; Viel S; Rodero MP; Crow YJ; Bader-Meunier B
Rheumatology (Oxford); 2020 Aug; 59(8):1927-1937. PubMed ID: 31755959
[TBL] [Abstract][Full Text] [Related]
8. Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis.
Benvenuto S; Gortani G; Bussani R; Poropat F; Murru FM; Carrozzi M; Tommasini A; Taddio A
Ital J Pediatr; 2021 Jul; 47(1):146. PubMed ID: 34210321
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
[TBL] [Abstract][Full Text] [Related]
10. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
11. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
Wang L; Liu L; Hao H; Gao F; Liu X; Wang Z; Zhang W; Lv H; Yuan Y
Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
[TBL] [Abstract][Full Text] [Related]
13. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
14. Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis.
Kimura M; Aizawa A; Kudou R; Rikitake Y; Iwao C; Rikitake M; Iwao K; Kariya Y; Kawaguchi T; Matsuda M; Miyauchi S; Takajo I; Umekita K
Clin Exp Rheumatol; 2024 Feb; 42(2):321-328. PubMed ID: 37497714
[TBL] [Abstract][Full Text] [Related]
15. [Anti-SRP myopathy: different entity from myositis].
Suzuki S
Rinsho Shinkeigaku; 2012; 52(11):1148-50. PubMed ID: 23196545
[TBL] [Abstract][Full Text] [Related]
16. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody.
De Souza FHC; Miossi R; Shinjo SK
Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort.
Basnayake SK; Blumbergs P; Tan JA; Roberts-Thompson PJ; Limaye V
Clin Rheumatol; 2015 Mar; 34(3):603-8. PubMed ID: 24497174
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
20. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
